Runwal Enterprises Limited IPO
RUNWALENTR · Mainboard · 25–29 Sep 2026 · archived record
Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.
No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.
No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.
All of this IPO is a fresh issue: every rupee raised goes to the company.
- ₹100 Cr: repay the company's own borrowings
- ₹225 Cr: invest in two subsidiaries (Runwal Residency, Evie Real Estate) so they can repay their loans
- Up to 35% of the issue: buying future projects plus general corporate purposes
- 100% fresh issue: no promoter is selling
Qualified institutional buyers are mutual funds, banks, insurers and foreign funds, and they read the full prospectus. They usually bid on the last day, so a low QIB number early in the window is normal. A low one at the close is not.
Promoter holding: 80.9% before the issue; about 72% after (our estimate at ₹302, as the RHP leaves it blank)
- Revenue: ₹2,408.9 Cr (FY24) → ₹1,007.8 Cr (FY25) → ₹1,799.0 Cr (FY26)
- Profit: ₹93.7 Cr → ₹55.6 Cr → ₹185.8 Cr
- Real-estate revenue is lumpy: it is booked when projects are handed over
- Net debt ₹2,778 Cr in FY26, 3.3× equity
- About 18× FY26 earnings at ₹302 (diluted EPS ₹16.74)
- The RHP's listed real-estate peers average 39× (range 21×–58×, prices as of 18 Sep 2026)
- About 4× book value (NAV ₹75 per share after CCD conversion)
- FY26 RoNW of 27.2%
- Most of the money goes to paying down debt, which should cut interest costs
- Heavy debt: net debt/equity was 3.3× even after FY26
- 66.65% of projects are in Mumbai
- 7,072 unsold units (7.55 mn sq ft) as of March 2026
- All 33 upcoming projects still await finalised plans and approvals
- Past delays in paying employee statutory dues
- Source: Runwal Enterprises RHP filed with NSE, September 2026
In 3 of the last 5 years, the typical Realty stock did better than the typical listed stock.
| Year | Typical stock | Clean average | Stocks up | Whole market | Abnormal moves set aside |
|---|---|---|---|---|---|
| 2021 | +73.0% | +92.0% | 100% of 12 | +45.5% | None |
| 2022 | -5.1% | +1.2% | 31% of 13 | +3.0% | None |
| 2023 | +92.8% | +90.7% | 100% of 13 | +43.5% | TARC +221.6% |
| 2024 | +41.2% | +40.9% | 93% of 14 | +23.1% | ANANTRAJ +189.9% |
| 2025 | -25.7% | -22.2% | 6% of 16 | -4.2% | None |
| 2026 YTD | -13.8% | -8.9% | 35% of 17 | -2.8% | None |
Calendar-year returns of the Realty companies in the Nifty Total Market index, adjusted for splits and bonuses. The typical stock is the median, so one stock's spike or crash cannot pass for the whole sector. Moves more than three interquartile ranges from the middle are named and left out of the clean average. Only companies listed today are counted, so ones that collapsed and delisted are missing and past returns look better than they were. Past sector returns say nothing certain about this IPO.
Use NSE's official IPO bid and allotment verification page.
nseindia.comWhat is the GMP of Runwal Enterprises Limited today?
The latest unofficial grey market premium for Runwal Enterprises Limited is — (0.66% of the upper price band), sourced from InvestorGain. GMP is unofficial and unregulated.
What is the price band of Runwal Enterprises Limited?
The price band is ₹290–₹302 per share, as filed with NSE.
When does Runwal Enterprises Limited open and close?
The issue window is 25–29 Sep 2026. The current status is closed.
How much is Runwal Enterprises Limited subscribed?
Live subscription figures are published by NSE once bidding opens.
Is Runwal Enterprises Limited a good IPO to apply for?
Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.
↑Issue schedule verified from NSE
!GMP is unofficial and not verified by NSE
!Read the RHP risk factors before applying
Schedule, price band and live subscription data are sourced from NSE India. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.